Skip to content

AOCI at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$2.5B-6.6%
Natera, Inc. logo
Natera, Inc.NTRA
-$202K-2.5%
NeoGenomics logo
NeoGenomicsNEO
$4K+107%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$70K-289%
GeneDx Holdings logo
GeneDx HoldingsWGS
$683K-24.5%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$2K+101%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's AOCI?
CareDx (CDNA) reported AOCI of -$6.27M in Q1 2026.
How has CareDx's AOCI changed year-over-year?
CareDx's AOCI increased by 11.5% year-over-year, from -$7.09M to -$6.27M.
What is the long-term trend for CareDx's AOCI?
Over 5 years (2020 to 2025), CareDx's AOCI has grown at a 21.3% compound annual growth rate (CAGR), from -$2.1M to -$5.52M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.